Categories: HealthcareNews

Astrana Health, Inc. to Participate in Upcoming Investor Conference

ALHAMBRA, Calif., Dec. 19, 2024 /PRNewswire/ — Astrana Health, Inc. (“Astrana,” and together with its subsidiaries and affiliated entities, the “Company”) (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that leadership is participating in the J.P. Morgan 2025 Healthcare Conference, being held in San Francisco, on Tuesday, January 14, 2024, including a presentation at 10:30am PT from President and CEO of Astrana Health, Brandon Sim. The webcast link and related presentation materials will be available in the “IR Calendar” section of the Company’s website: https://ir.astranahealth.com/news-events/ir-calendar.

About Astrana Health, Inc.

Astrana is a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all. Leveraging its proprietary end-to-end technology solutions, Astrana operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver high quality care to patients in a cost-effective manner.

Headquartered in Alhambra, California, Astrana serves over 12,000 providers and over 1.1 million Americans in value-based care arrangements. Its subsidiaries and affiliates include management services organizations (MSOs), affiliated independent practice associations (IPAs), accountable care organizations (ACOs), and care delivery entities across primary, multi-specialty, and ancillary care. For more information, please visit www.astranahealth.com.

FOR MORE INFORMATION, PLEASE CONTACT:
Investor Relations
(626) 943-6491
Asher Dewhurst, ICR Healthcare
investors@astranahealth.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/astrana-health-inc-to-participate-in-upcoming-investor-conference-302336639.html

SOURCE Astrana Health, Inc.

Staff

Recent Posts

FendX Announces RSU Grant

Oakville, Ontario--(Newsfile Corp. - December 19, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF)…

3 hours ago

AngioDynamics to Report Fiscal 2025 Second Quarter Financial Results on January 8, 2025 and Host Virtual NanoKnife Investor Event

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on…

7 hours ago

Array Behavioral Care Achieves HITRUST e1 Certification Demonstrating Foundational Cybersecurity

HITRUST e1 Certification validates Array Behavioral Care is committed to foundational cybersecurity controls and information…

7 hours ago

Astraveus Secures €7.1M Non-dilutive Funding from the French State

PARIS, Dec. 19, 2024 /PRNewswire/ -- Astraveus SAS ("Astraveus" or the "Company"), the Benchtop Cell…

7 hours ago

Bryan Johnson, Dave Asprey, Dr Michael Ashenden United With Olympians and Anti-Doping Experts to Forge the Future of Human Enhancement

Historic Second Conference on Human Enhancement brought together world leaders in sports and science. Leading…

7 hours ago

Predictive Safety Announces Partnership with DISA Global Solutions

DENVER, Dec. 19, 2024 /PRNewswire/ -- Predictive Safety is thrilled to unveil our new strategic…

7 hours ago